Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oxford BioMedica makes appointment

This article was originally published in Scrip

Executive Summary

The gene therapy company Oxford BioMedica(UK) has announced that John Dawson will join its board on August 1st as a non-executive director and member of the remuneration and audit committees. From 1996 to 2007, Mr Dawson held senior management positions in the European operations of Cephalon, including from 2005 as chief financial officer and head of business development Europe.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts